A citation-based method for searching scientific literature

Maria Caiata-Zufferey, Olivia Pagani, Viviane Cina, Véronique Membrez, Monica Taborelli, Sheila Unger, Anne Murphy, Christian Monnerat, Pierre O Chappuis. Genet Med 2015
Times Cited: 7

List of co-cited articles
33 articles co-cited >1

Times Cited
  Times     Co-cited

Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process.
Catharine Wang, Richard Gonzalez, Kara J Milliron, Victor J Strecher, Sofia D Merajver. Am J Med Genet A 2005

Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
Andrea Farkas Patenaude, Michel Dorval, Lisa S DiGianni, Katherine A Schneider, Anu Chittenden, Judy E Garber. J Clin Oncol 2006

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.
Angela R Bradbury, Comfort N Ibe, James J Dignam, Shelly A Cummings, Marion Verp, Melody A White, Grazia Artioli, Laura Dudlicek, Olufunmilayo I Olopade. Genet Med 2008

Risk management options elected by women after testing positive for a BRCA mutation.
Christine Garcia, Jacqueline Wendt, Liisa Lyon, Jennifer Jones, Ramey D Littell, Mary Anne Armstrong, Tina Raine-Bennett, C Bethan Powell. Gynecol Oncol 2014

Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Tara M Friebel, Susan M Domchek, Susan L Neuhausen, Theresa Wagner, D Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Clin Breast Cancer 2007

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014

Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study.
Maria C Katapodi, Deb Duquette, James J Yang, Kari Mendelsohn-Victor, Beth Anderson, Christos Nikolaidis, Emily Mancewicz, Laurel L Northouse, Sonia Duffy, David Ronis,[...]. Cancer Causes Control 2017

Validation of a decision regret scale.
Jamie C Brehaut, Annette M O'Connor, Timothy J Wood, Thomas F Hack, Laura Siminoff, Elisa Gordon, Deb Feldman-Stewart. Med Decis Making 2003

Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
Maria C Katapodi, Michelle L Munro, Penny F Pierce, Reg A Williams. Nurs Res 2011

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012

Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
Maria C Katapodi, Laurel L Northouse, Kara J Milliron, Guipeng Liu, Sofia D Merajver. Psychooncology 2013

The influence of social support on breast cancer screening in a multicultural community sample.
Maria C Katapodi, Noreen C Facione, Christine Miaskowski, Marilyn J Dodd, Catherine Waters. Oncol Nurs Forum 2002

BRCA in breast cancer: ESMO Clinical Practice Guidelines.
J Balmaña, O Díez, I T Rubio, F Cardoso. Ann Oncol 2011

Availability and payer coverage of BRCA1/2 tests and gene panels.
Elizabeth Clain, Julia R Trosman, Michael P Douglas, Christine B Weldon, Kathryn A Phillips. Nat Biotechnol 2015

BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer.
F Schoumacher, A Glaus, H Mueller, U Eppenberger, B Bolliger, H J Senn. Swiss Med Wkly 2001

Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing.
Julien Mancini, Catherine Noguès, Claude Adenis, Pascaline Berthet, Valerie Bonadona, Agnès Chompret, Isabelle Coupier, François Eisinger, Jean-Pierre Fricker, Marion Gauthier-Villars,[...]. Eur J Cancer 2006

Population screening for genetic disorders in the 21st century: evidence, economics, and ethics.
S D Grosse, W H Rogowski, L F Ross, M C Cornel, W J Dondorp, M J Khoury. Public Health Genomics 2010

Testing participation in BRCA1/2-positive families: initiator role of index cases.
Cécile Blandy, Françoise Chabal, Dominique Stoppa-Lyonnet, Claire Julian-Reynier. Genet Test 2003

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003

Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
Erna Claes, Gerry Evers-Kiebooms, Andrea Boogaerts, Marleen Decruyenaere, Lieve Denayer, Eric Legius. Am J Med Genet A 2003

Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer.
Joan L Walker, C Bethan Powell, Lee-May Chen, Jeanne Carter, Victoria L Bae Jump, Lynn P Parker, Mark E Borowsky, Randall K Gibb. Cancer 2015

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
Paul A Harris, Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G Conde. J Biomed Inform 2009

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
Marc D Schwartz, Elizabeth Kaufman, Beth N Peshkin, Claudine Isaacs, Chanita Hughes, Tiffani DeMarco, Clinton Finch, Caryn Lerman. J Clin Oncol 2003

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Chanita Hughes Halbert, Tiffani DeMarco, William Lawrence, David Main, Clinton Finch, Colette Magnant,[...]. J Clin Oncol 2004

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979

Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.
Beth N Peshkin, Marc D Schwartz, Claudine Isaacs, Chanita Hughes, David Main, Caryn Lerman. Cancer Epidemiol Biomarkers Prev 2002

Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred.
Anita Yeomans Kinney, Sara Ellis Simonsen, Bonnie Jeanne Baty, Diptasri Mandal, Susan L Neuhausen, Kate Seggar, Richard Holubkov, Lindsey Bloor, Ken Smith. J Genet Couns 2006

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006

Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers.
T Pal, J-H Lee, A Besharat, Z Thompson, A N A Monteiro, C Phelan, J M Lancaster, K Metcalfe, T A Sellers, S Vadaparampil,[...]. Clin Genet 2014

Validity of women's self-reports of cancer screening test utilization in a managed care population.
Lee S Caplan, David V McQueen, Judith R Qualters, Marilyn Leff, Carol Garrett, Ned Calonge. Cancer Epidemiol Biomarkers Prev 2003

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics.
Claire Julian-Reynier, Anne-Déborah Bouhnik, Emanuelle Mouret-Fourme, Marion Gauthier-Villars, Pascaline Berthet, Christine Lasset, Jean-Pierre Fricker, Olivier Caron, Paul Gesta, Elisabeth Luporsi,[...]. Genet Med 2010

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Lauren Scheuer, Noah Kauff, Mark Robson, Bridget Kelly, Richard Barakat, Jaya Satagopan, Nathan Ellis, Martee Hensley, Jeff Boyd, Patrick Borgen,[...]. J Clin Oncol 2002

Mammography use among sociodemographically diverse women: the accuracy of self-report.
J G Zapka, C Bigelow, T Hurley, L D Ford, J Egelhofer, W M Cloud, E Sachsse. Am J Public Health 1996

Three approaches to qualitative content analysis.
Hsiu-Fang Hsieh, Sarah E Shannon. Qual Health Res 2005

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.